CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CADENCE aims to revolutionize cancer therapy by using heterogeneous catalysis to target tumors. The project focuses on delivering catalysts directly to tumors and activating them remotely to deplete growth-promoting molecules and generate toxic byproducts.
Despite intense research efforts in almost every branch of the natural sciences, cancer continues to be one of the leading causes of death worldwide.
It is thus remarkable that little or no therapeutic use has been made of a whole discipline, heterogeneous catalysis, which is noted for its specificity and for enabling chemical reactions in otherwise passive environments.
At least in part, this could be attributed to practical difficulties: the selective delivery of a catalyst to a tumour and the…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
